Ananda K. Kanduluru - Publications

Affiliations: 
2016- On Target Laboratory 

11 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Kanduluru AK, Srinivasarao M, Wayua C, Low PS. Evaluation of a Neurokinin-1 Receptor-Targeted Technetium-99m Conjugate for Neuroendocrine Cancer Imaging. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. PMID 31292915 DOI: 10.1007/S11307-019-01391-W  0.96
2018 Lee YG, Marks I, Srinivasarao M, Kanduluru AK, Mahalingam SM, Liu X, Chu H, Low PS. Use of a single CAR T cell and several bispecific adapters facilitates eradication of multiple antigenically different solid tumors. Cancer Research. PMID 30482775 DOI: 10.1158/0008-5472.Can-18-1834  0.96
2018 Kularatne SA, Thomas M, Myers CH, Gagare P, Kanduluru AK, Crain CJ, Cichocki BN. Evaluation of Novel Prostate-Specific Membrane Antigen-Targeted Near-Infrared Imaging Agent for Fluorescence-Guided Surgery for Prostate Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30201762 DOI: 10.1158/1078-0432.Ccr-18-0803  0.96
2018 Zhang H, Kanduluru AK, Desai P, Ahad A, Carlin SD, Tandon N, Weber W, Low PS. Synthesis and evaluation of a novelCu/Ga-labeled neurokinin 1 receptor antagonist for in vivo targeting of NK1R-positive tumor xenografts. Bioconjugate Chemistry. PMID 29466853 DOI: 10.1021/Acs.Bioconjchem.8B00063  0.96
2018 Rangasamy L, Chelvam V, Kanduluru AK, Srinivasarao M, Bandara AN, You F, Orellana E, Kasinski AL, Low PS. New mechanism for release of endosomal contents: osmotic lysis via nigericin-mediated K/Hexchange. Bioconjugate Chemistry. PMID 29446616 DOI: 10.1021/Acs.Bioconjchem.7B00714  0.96
2017 Kanduluru AK, Low PS. Development of a Ligand-Targeted Therapeutic Agent for Neurokinin-1 Receptor Expressing Cancers. Molecular Pharmaceutics. PMID 28969417 DOI: 10.1021/Acs.Molpharmaceut.7B00583  0.96
2016 Kanduluru AK, Srinivasarao M, Low PS. Design, Synthesis and Evaluation of a Neurokinin 1 Receptor-Targeted Near IR Dye for Fluorescence Guided Surgery of Neuroendocrine Cancers. Bioconjugate Chemistry. PMID 27529726 DOI: 10.1021/Acs.Bioconjchem.6B00374  0.96
2016 Chen J, van Dongen MA, Merzel RL, Dougherty CA, Orr BG, Kanduluru AK, Low PS, Marsh EN, Banaszak Holl MM. Substrate-Triggered Exosite Binding: Synergistic Dendrimer/Folic Acid Action for Achieving Specific, Tight-Binding to Folate Binding Protein. Biomacromolecules. PMID 26815158 DOI: 10.1021/Acs.Biomac.5B01586  0.32
2015 Roy J, Nguyen TX, Kanduluru AK, Venkatesh C, Lv W, Reddy PV, Low PS, Cushman M. DUPA conjugation of a cytotoxic indenoisoquinoline topoisomerase I inhibitor for selective prostate cancer cell targeting. Journal of Medicinal Chemistry. 58: 3094-103. PMID 25822623 DOI: 10.1021/Jm5018384  0.32
2014 van Dongen MA, Silpe JE, Dougherty CA, Kanduluru AK, Choi SK, Orr BG, Low PS, Banaszak Holl MM. Avidity mechanism of dendrimer-folic acid conjugates. Molecular Pharmaceutics. 11: 1696-706. PMID 24725205 DOI: 10.1021/Mp5000967  0.32
2013 Kanduluru AK, Banerjee P, Beutler JA, Fuchs PL. A convergent total synthesis of the potent cephalostatin/ritterazine hybrid -25-epi ritterostatin GN1N. The Journal of Organic Chemistry. 78: 9085-92. PMID 23899273 DOI: 10.1021/Jo401171Q  0.32
Show low-probability matches.